134 related articles for article (PubMed ID: 9816221)
41. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
Kang MH; Harutyunyan N; Hall CP; Papa RA; Lock RB
Br J Haematol; 2009 May; 145(3):389-93. PubMed ID: 19298590
[TBL] [Abstract][Full Text] [Related]
44. Trimetrexate: clinical development of a nonclassical antifolate.
O'Dwyer PJ; DeLap RJ; King SA; Grillo-Lopez AJ; Hoth DF; Leyland-Jones B
NCI Monogr; 1987; (5):105-9. PubMed ID: 2963228
[TBL] [Abstract][Full Text] [Related]
45. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
46. Analogues of methotrexate in rheumatoid arthritis. 2. Effects of 5-deazaaminopterin, 5,10-dideazaaminopterin, and analogues on type II collagen-induced arthritis in mice.
Piper JR; DeGraw JI; Colwell WT; Johnson CA; Smith RL; Waud WR; Sirotnak FM
J Med Chem; 1997 Jan; 40(3):377-84. PubMed ID: 9022805
[TBL] [Abstract][Full Text] [Related]
47. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
48. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
49. Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.
Izbicka E; Diaz A; Streeper R; Wick M; Campos D; Steffen R; Saunders M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):993-9. PubMed ID: 19221750
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
51. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
52. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
53. L-asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y.
Sur P; Fernandes DJ; Kute TE; Capizzi RL
Cancer Res; 1987 Mar; 47(5):1313-8. PubMed ID: 2434214
[TBL] [Abstract][Full Text] [Related]
54. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
[TBL] [Abstract][Full Text] [Related]
55. Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Wang ES; O'Connor O; She Y; Zelenetz AD; Sirotnak FM; Moore MA
Leuk Lymphoma; 2003 Jun; 44(6):1027-35. PubMed ID: 12854905
[TBL] [Abstract][Full Text] [Related]
56. Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate, LY231514.
Worzalla JF; Shih C; Schultz RM
Anticancer Res; 1998; 18(5A):3235-9. PubMed ID: 9858888
[TBL] [Abstract][Full Text] [Related]
57. A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro.
Smith A; Hum M; Winick NJ; Kamen BA
Clin Cancer Res; 1996 Jan; 2(1):69-73. PubMed ID: 9816092
[TBL] [Abstract][Full Text] [Related]
58. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
59. Improvement of the antitumor activity of intraperitoneally and orally administered 5,6-dimethylxanthenone-4-acetic acid by optimal scheduling.
Zhao L; Ching LM; Kestell P; Baguley BC
Clin Cancer Res; 2003 Dec; 9(17):6545-50. PubMed ID: 14695159
[TBL] [Abstract][Full Text] [Related]
60. 10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
Krug LM; Azzoli CG; Kris MG; Miller VA; Khokhar NZ; Tong W; Ginsberg MS; Venkatraman E; Tyson L; Pizzo B; Baez V; Ng KK; Sirotnak FM
Clin Cancer Res; 2003 Jun; 9(6):2072-8. PubMed ID: 12796370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
